Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPEED: Symbicort vs Seretide in COPD
NCT00542880Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2007
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 4 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Sep 2007; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00542880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542880.